Roivant Sciences Ltd. Common Shares vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $339.46M). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 73.9× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| ROIV | XDTE | |
|---|---|---|
Market Cap | $25.09B | $339.46M |
Volume | 5,738,571 | 214,614 |
Sector | Health | Income / Options Overlay |
52-Week High | $41.81 | $44.76 |
52-Week Low | $16.04 | $36.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $21.36B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →